Showing results (71-80 of 155) with videos related to
Sort By:
Pageof 16
JAMA|September 9, 2010
Clinical characteristics and 30-day outcomes for influenza A 2009 (H1N1), 2008-2009 (H1N1), and 2007-2008 (H3N2) infectionsEdward A Belongia, Stephanie A Irving, Stephen C Waring, et al.The Journal of Infectious Diseases|January 22, 2010
Mask use, hand hygiene, and seasonal influenza-like illness among young adults: a randomized intervention trialAllison E Aiello, Genevra F Murray, Vanessa Perez, et al.Vaccine|March 28, 2015
Deaths averted by influenza vaccination in the U.S. during the seasons 2005/06 through 2013/14Ivo M Foppa, Po-Yung Cheng, Sue B Reynolds, et al.MMWR. Morbidity and Mortality Weekly Report|December 30, 2021
COVID-19 Vaccine Safety in Children Aged 5-11 Years - United States, November 3-December 19, 2021Anne M Hause, James Baggs, Paige Marquez, et al.MMWR. Morbidity and Mortality Weekly Report|August 18, 2022
Safety Monitoring of Pfizer-BioNTech COVID-19 Vaccine Booster Doses Among Children Aged 5-11 Years - United States, May 17-July 31, 2022Anne M Hause, James Baggs, Paige Marquez, et al.Vaccine|August 27, 2005
Assessment of the safety of a third dose of pneumococcal polysaccharide vaccine in the Vaccine Safety Datalink populationLisa A Jackson, Jennifer C Nelson, Cynthia G Whitney, et al.MMWR. Morbidity and Mortality Weekly Report|May 6, 2021
Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine - United States, March-April 2021David K Shay, Julianne Gee, John R Su, et al.American Journal of Epidemiology|August 28, 2013
Further evidence for bias in observational studies of influenza vaccine effectiveness: the 2009 influenza A(H1N1) pandemicMichael L Jackson, Onchee Yu, Jennifer C Nelson, et al.MMWR. Morbidity and Mortality Weekly Report|June 8, 2023
Safety Monitoring of mRNA COVID-19 Vaccine Third Doses Among Children Aged 6 Months-5 Years - United States, June 17, 2022-May 7, 2023Anne M Hause, Paige Marquez, Bicheng Zhang, et al.MMWR. Morbidity and Mortality Weekly Report|January 12, 2023
Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5-11 Years - United States, October 12-January 1, 2023Anne M Hause, Paige Marquez, Bicheng Zhang, et al.Pageof 16